PT Darya-Varia Laboratoria Tbk (IDX:DVLA)
Indonesia · Delayed Price · Currency is IDR 1,570.00
0.00 (0.00%)
Oct 30, 2026, 3:48 PM WIB
IDX:DVLA Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,452,049 | 2,231,749 | 2,087,601 | 1,890,888 | 1,917,041 | 1,900,894 |
Revenue Growth | 15.49% | 6.91% | 10.40% | -1.36% | 0.85% | 3.89% |
Gross Profit Gross Profit Growth | 1,244,381 | 1,207,436 | 1,092,543 | 975,240 | 1,006,123 | 995,768 |
Operating Income Operating Income Growth | 187,420 | 215,694 | 199,779 | 189,284 | 189,966 | 195,419 |
Net Income Net Income Growth | 142,285 | 163,947 | 156,147 | 146,336 | 149,375 | 146,505 |
Earnings Per Share EPS Growth | 126.58 | 146.38 | 139.42 | 130.66 | 133.37 | 130.81 |
EPS Growth | -18.21% | 5.00% | 6.70% | -2.03% | 1.96% | -9.61% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Export & Toll Manufacturing Export & Toll Manufacturing Growth | 256,687 | 201,577 | 193,703 | 221,121 | 297,719 |
Prescription Drugs Prescription Drugs Growth | 666,224 | 705,228 | 708,418 | 638,668 | 660,424 |
Consumer Health Products Consumer Health Products Growth | 1,259,294 | 1,154,286 | 961,782 | 1,057,253 | 942,750 |
Services Services Growth | 49,544 | 26,509 | 26,984 | - | - |
Total Total Growth | 2,231,749 | 2,087,601 | 1,890,888 | 1,917,041 | 1,900,894 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 360,763 | 341,559 | 357,823 | 240,043 | 357,021 | 583,296 |
Total Debt Total Debt Growth | 75 | 206.87 | 1,044 | 1,474 | 1,888 | 22,981 |
Net Cash (Debt) Net Cash Growth | 360,688 | 341,352 | 356,779 | 238,569 | 355,133 | 560,315 |
Net Cash Growth | -11.34% | -4.32% | 49.55% | -32.82% | -36.62% | 111.98% |
Net Cash Per Share Net Cash Per Share Growth | 320.87 | 304.78 | 318.55 | 213.01 | 317.08 | 500.28 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 131,649 | 201,177 | 331,763 | 109,186 | -16,060 | 435,164 |
Capital Expenditures CapEx Growth | -106,543 | -107,321 | -102,648 | -97,916 | -58,185 | -84,944 |
Free Cash Flow Free Cash Flow Growth | 25,106 | 93,856 | 229,115 | 11,270 | -74,245 | 350,220 |
Free Cash Flow Growth | -69.63% | -59.04% | 1932.99% | - | - | 700.02% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.75% | 54.10% | 52.34% | 51.58% | 52.48% | 52.38% |
Operating Margin | 7.64% | 9.66% | 9.57% | 10.01% | 9.91% | 10.28% |
Pretax Margin | 7.79% | 9.87% | 10.05% | 10.13% | 10.49% | 11.13% |
Profit Margin | 5.80% | 7.35% | 7.48% | 7.74% | 7.79% | 7.71% |
FCF Margin | 1.02% | 4.21% | 10.97% | 0.60% | -3.87% | 18.42% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 105.000 | 105.000 | 110.000 | 108.000 | 119.000 | 114.000 |
Dividend Per Share Growth | -4.55% | -4.54% | 1.85% | -9.24% | 4.39% | 3.64% |
Dividend Yield | 6.69% | 6.36% | 6.88% | 6.49% | 5.02% | 4.15% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.40 | 11.27 | 11.48 | 12.74 | 17.77 | 21.02 |
P/FCF Ratio | 70.04 | 19.69 | 7.82 | 165.47 | - | 8.79 |
PS Ratio | 0.72 | 0.83 | 0.86 | 0.99 | 1.39 | 1.62 |